PHARMA NORD ApS — Credit Rating and Financial Key Figures

CVR number: 67303016

Tinglykke 4-6, Skrydstrup 6500 Vojens

tel: 74541155

Income statement (mDKK)

	2019	2020	2021	2022	2023
Fiscal period length	12	12	12	12	12
Net sales	332.99	417.18	470.18	439.44	447.39
Change in finished goods inventory	9.98
Manufacturing for enterprise's own use	-2.81	-3.22	-3.49	-3.59	-1.90
Other operating income		0.27	1.48	2.54	1.56
Purchases during the financial year	-80.33	-84.17	-97.14	-79.24	- 105.56
External services	- 139.32	- 138.62	- 155.52	- 178.80	- 197.70
Gross profit	126.14	197.88	222.48	187.53	147.58
Employee benefit expenses	-92.39	- 139.11	- 153.51	- 138.01	- 119.24
Other operating expenses	-0.00		-0.03
Total depreciation	-8.69	-9.14	-9.86	-10.88	-10.73
EBIT	25.05	49.62	59.08	38.65	17.61
Other financial income	2.67	1.83	1.75	0.92	1.41
Other financial expenses	-2.04	-3.95	-1.55	-5.02	-8.39
Reduction non-current investment assets			-0.22
Income from other inv. held as non-curr. assets	0.01		0.01	0.01	0.01
Net income from associates (fin.)	21.49	14.91	11.98	8.52	15.38
Pre-tax profit	47.17	62.41	71.05	43.08	26.02
Income taxes	-5.67	-10.46	-13.08	-7.79	-2.69
Net earnings	41.50	51.95	57.97	35.29	23.34

	2019	2020	2021	2022	2023
Development expenditure	1.81	1.49	1.08	1.09	1.46
Intangible assets total	1.81	1.49	1.08	1.09	1.46
Land and waters	114.36	116.34	118.44	120.53	122.41
Buildings	9.49	10.47	11.32	10.97	12.75
Machinery and equipment	4.40	4.33	18.71	17.85	16.42
Tangible assets total	128.25	131.15	148.47	149.35	151.58
Holdings in group member companies	44.93	47.58	45.15	36.04	47.90
Investments total	44.93	47.58	45.15	36.04	47.90
Non-current loans receivable	0.01	0.00	0.01	0.01	0.01
Long term receivables total	0.01	0.00	0.01	0.01	0.01
Semifinished products	12.10	18.25	7.95	21.07	29.69
Raw materials and consumables	35.09	38.39	37.62	51.35	46.74
Finished products/goods	25.96	21.87	26.23	38.87	28.41
Inventories total	73.15	78.51	71.80	111.29	104.84
Current trade debtors	60.12	75.53	74.99	68.28	57.01
Current amounts owed by group member comp.	50.05	54.14	74.83	64.28	50.44
Prepayments and accrued income	1.21	1.18	0.43	0.68	0.58
Current other receivables	3.50	2.86	2.42	2.27	2.55
Short term receivables total	114.88	133.72	152.67	135.51	110.57
Other current investments	15.74	16.62	17.66
Cash and bank deposits	13.78	5.96	23.74	13.71	10.73
Cash and cash equivalents	29.52	22.58	41.39	13.71	10.73
Balance sheet total (assets)	392.56	415.02	460.57	447.01	427.09

	2019	2020	2021	2022	2023
Share capital	0.20	0.20	0.20	0.20	0.20
Shares repurchased	100.00	30.00	50.00	45.00
Other reserves	0.52	0.46	3.87	0.85	3.44
Retained earnings	127.51	87.82	87.31	101.69	133.59
Profit of the financial year	41.50	51.95	57.97	35.29	23.34
Shareholders equity total	269.73	170.43	199.35	183.03	160.56
Provisions	12.21	13.57	14.01	17.23	17.70
Non-current loans from credit institutions	39.03	35.50	53.73	51.07	48.41
Non-current other liabilities	1.30	4.78
Non-current liabilities total	40.33	40.27	53.73	51.07	48.41
Current loans from credit institutions	8.25	52.98	80.73	90.85	151.42
Current trade creditors	40.34	22.33	19.59	18.78	22.34
Current owed to participating	0.48	0.44	0.44	0.38	0.53
Current owed to group member	4.00	54.57	3.67	45.18	5.24
Short-term deferred tax liabilities	3.91	9.10	12.54	4.28	2.12
Other non-interest bearing current liabilities	13.31	51.33	76.50	36.21	18.77
Current liabilities total	70.29	190.75	193.48	195.69	200.42
Balance sheet total (liabilities)	392.56	415.02	460.57	447.01	427.09

Try the full version of our system for free

... and more!

No registration needed.